![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 58861-48-6
2. 2-(4-fluorophenyl)-thiophene
3. 2-(4-fluoro-phenyl)-thiophene
4. 72tg563tmb
5. Canagliflozin Related Impurity 14
6. Mfcd06802535
7. Thiophene, 2-(4-fluorophenyl)-
8. 4-fluorophenylthiphene
9. Ec 611-756-1
10. Unii-72tg563tmb
11. Schembl154088
12. Amy8652
13. Dtxsid60619591
14. Bcp22383
15. Cs-m2131
16. Zinc8764139
17. Bbl103247
18. Geo-03158
19. Stl557057
20. Akos004118865
21. Pb10393
22. Ac-29154
23. Ds-15181
24. Sy042584
25. Db-013907
26. Bb 0223633
27. F0724
28. Ft-0657107
29. P10422
30. 861f486
31. A832044
32. J-505998
Molecular Weight | 178.23 g/mol |
---|---|
Molecular Formula | C10H7FS |
XLogP3 | 3.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 178.02524956 g/mol |
Monoisotopic Mass | 178.02524956 g/mol |
Topological Polar Surface Area | 28.2 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 141 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.